pharmaceutical investing Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm Sublingual Film
pharmaceutical investing Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer
pharmaceutical investing Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635
pharmaceutical investing Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
pharmaceutical investing Aquestive Therapeutics to Participate in Upcoming March Investor Conferences
pharmaceutical investing Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
pharmaceutical investing Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
pharmaceutical investing Aquestive Therapeutics to Present New Clinical Data on Anaphylm Sublingual Film at the 2026 AAAAI Annual Meeting
pharmaceutical investing Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
pharmaceutical investing Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm
pharmaceutical investing Aquestive Therapeutics Announces Regulatory Development for Anaphylm Sublingual Film and Provides Business Update
pharmaceutical investing Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
pharmaceutical investing Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
pharmaceutical investing Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
Metalsource Mining Intersects 48.04 g/t AuEq over 12.62m, Including 210.72 g/t AuEq over 2.74m, Extends Mineralization down Dip 195m, Continues to Expand Gold, Silver and Base Metal Mineralization
EnerCom Opens Registration for the 31st Annual Energy Investment Conference August 17-19, 2026 in Denver, Colorado
